Dubai: Hussain Nasser Al Rahma, Founding President of the Emirates Intensive Care Society under the Emirates Medical Association and Founding Chairman of the Emirates Critical Care Conference, announced that the event has become a leading platform across the Gulf, the Middle East, and North Africa for global manufacturers of medical devices and healthcare technologies.
According to Emirates News Agency, Al Rahma highlighted during the conference at InterContinental Dubai Festival City that international companies are increasingly selecting the UAE as the launchpad for their latest innovations, recognizing it as a strategic gateway to the rapidly expanding regional healthcare markets. The conference featured a new generation of dual-action antibiotic therapies designed to combat infections and fungal diseases. Clinical studies on patients receiving these therapies showed promising outcomes, including faster recovery and shorter hospital stays.
Al Rahma also emphasized the advanced artificial intelligence-driven medical technologies showcased at the event, including a device equipped with sensors around the patient's head to analyze brain activity in real time. This system aids anaesthesiologists by providing detailed neurological data, accurately determining anaesthesia levels required during surgical procedures, and continuously monitoring patient consciousness and dosage needs. The AI-generated assessments reportedly achieve near-perfect accuracy.
Additionally, the conference unveiled an AI-powered aerosol drug delivery system resembling a ventilator, which facilitates precise administration of medication particles directly to targeted organs and treatment areas. This technology is particularly beneficial for paediatric patients who often struggle with oral medication intake.
Al Rahma mentioned in statements to WAM that artificial intelligence is revolutionizing Intensive Care Units (ICUs) by improving survival and recovery rates through real-time analysis of large volumes of patient data, supporting faster clinical decision-making. Predictive analytics and AI-powered early-warning systems can anticipate critical deterioration in patient conditions such as acute heart failure and sepsis, allowing proactive medical intervention.
Moreover, AI technologies are enhancing continuous remote monitoring of patients by observing vital signs in real time, reducing administrative workloads, and enabling healthcare professionals to focus more on direct patient care. Al Rahma underscored that AI contributes to reducing human error, accelerating response times, and supporting personalized treatment plans tailored to individual patient conditions.
He concluded by asserting that artificial intelligence will complement rather than replace physicians or nursing teams, serving as an advanced supportive tool to enhance the accuracy of medical decisions and improve the efficiency of healthcare professionals in monitoring and clinical care.